SCHEMBL9597563

SCHEMBL9597563

Cc1c(CC2CCc3c(c4ccccc4n3C)C2=O)ncn1S(=O)(=O)N(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.52
CYP3A4 P08684 3/20 0.52
CYP1A2 P05177 2/20 0.52
HTR2B P41595 2/20 0.52
HTR3A P46098 2/20 0.52
CYP2D6 P10635 1/20 0.52
HTR3E A5X5Y0 1/20 0.52
SLC22A2 O15244 1/20 0.52
SLC22A1 O15245 1/20 0.52
SLC22A3 O75751 1/20 0.52
HTR3B O95264 1/20 0.52
CHRNB2 P17787 1/20 0.52
CHRNB4 P30926 1/20 0.52
CHRNA3 P32297 1/20 0.52
CHRNA4 P43681 1/20 0.52
HTR3D Q70Z44 1/20 0.52
SLC47A2 Q86VL8 1/20 0.52
HTR3C Q8WXA8 1/20 0.52
SLC47A1 Q96FL8 1/20 0.52
ADRA2C P18825 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14422555 0.90 KCNH2 (0.55) KCNH2CYP3A4CYP1A2HTR2BHTR3A
SCHEMBL7276207 0.83 CYP3A4 (0.35) KCNH2CYP3A4CYP1A2HTR2BHTR3A
SCHEMBL9596724 0.80 KCNH2 (0.54) KCNH2CYP3A4CYP1A2HTR2BHTR3A
SCHEMBL9596317 0.80 KCNH2 (0.56) KCNH2CYP3A4CYP1A2HTR2BHTR3A
SCHEMBL1101 0.79 KCNH2 (0.60) KCNH2CYP3A4CYP1A2HTR2BHTR3A
Galdansetron SCHEMBL635736 0.76 KCNH2 (0.61) KCNH2CYP3A4CYP1A2HTR2BHTR3A
Galdansetron SCHEMBL4564582 0.76 KCNH2 (0.61) KCNH2CYP3A4CYP1A2HTR2BHTR3A
SCHEMBL7276214 0.76 TSHR (0.35) CYP3A4TSHR
SCHEMBL10524130 0.76 CYP3A4 (0.51) KCNH2CYP3A4CYP1A2HTR2BHTR3A
Galdansetron SCHEMBL636713 0.75 CASP6 (0.62) KCNH2CYP3A4CYP1A2HTR2BHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5202343-A Treating anxiety, psychological disorders GLAXO GROUP LIMITED (GB) 1993-04-13 US disclosed
US-4859662-A Tetrahydro-imidazolylmethylcarbazolones and analogs thereof for treating 5-HT function disturbances GLAXO GROUP LIMITED (GB) 1989-08-22 US disclosed
US-4822881-A PSYCHOTIC DISORDERS, ANXIETY, NAUSEA, VOMITING GLAXO GROUP LIMITED 1989-04-18 US disclosed